ALIM logo

Alimera Sciences (ALIM) Cash From Financing

ALIM Annual CFF

$96.50 M
+$96.80 M+32053.31%

31 December 2023

ALIM Cash From Financing Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ALIM Quarterly CFF

-$4.32 M
-$7.28 M-245.43%

30 June 2024

ALIM Quarterly CFF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ALIM TTM CFF

-$1.97 M
-$91.44 M-102.20%

30 June 2024

ALIM TTM CFF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ALIM Cash From Financing Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+10000.0%-690.3%-102.0%
3 y3 years+2385.8%-143.4%-120.3%
5 y5 years+10000.0%-7339.7%-326.9%

ALIM Cash From Financing High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year
5 y5-year
alltimeall time-15.9%-105.0%-101.7%

Alimera Sciences Cash From Financing History

DateAnnualQuarterlyTTM
June 2024
-
-$4.32 M(-245.4%)
-$1.97 M(-102.2%)
Mar 2024
-
$2.97 M(-3903.8%)
$89.47 M(-7.3%)
Dec 2023
$96.50 M(<-9900.0%)
-$78.00 K(-85.7%)
$96.50 M(+0.1%)
Sept 2023
-
-$546.00 K(-100.6%)
$96.38 M(-0.6%)
June 2023
-
$87.13 M(+771.4%)
$96.98 M(+893.9%)
Mar 2023
-
$10.00 M(-5280.3%)
$9.76 M(-3331.1%)
Dec 2022
-$302.00 K(-103.1%)
-$193.00 K(-450.9%)
-$302.00 K(+135.9%)
Sept 2022
-
$55.00 K(-153.9%)
-$128.00 K(-44.8%)
June 2022
-
-$102.00 K(+64.5%)
-$232.00 K(-102.4%)
Mar 2022
-
-$62.00 K(+226.3%)
$9.82 M(-0.1%)
Dec 2021
$9.82 M(+153.0%)
-$19.00 K(-61.2%)
$9.82 M(+0.3%)
Sept 2021
-
-$49.00 K(-100.5%)
$9.80 M(+0.6%)
June 2021
-
$9.95 M(<-9900.0%)
$9.73 M(+590.4%)
Mar 2021
-
-$57.00 K(+23.9%)
$1.41 M(-63.7%)
Dec 2020
$3.88 M(+346.7%)
-$46.00 K(-58.2%)
$3.88 M(-22.3%)
Sept 2020
-
-$110.00 K(-106.8%)
$5.00 M(-1.0%)
June 2020
-
$1.62 M(-32.8%)
$5.05 M(+48.8%)
Mar 2020
-
$2.42 M(+125.9%)
$3.39 M(+290.6%)
Dec 2019
$869.00 K(-8.5%)
$1.07 M(-1943.1%)
$869.00 K(-486.2%)
Sept 2019
-
-$58.00 K(+81.3%)
-$225.00 K(-39.2%)
June 2019
-
-$32.00 K(-70.9%)
-$370.00 K(-5.9%)
Mar 2019
-
-$110.00 K(+340.0%)
-$393.00 K(-141.4%)
Dec 2018
$950.00 K(-83.4%)
-$25.00 K(-87.7%)
$950.00 K(+0.5%)
Sept 2018
-
-$203.00 K(+269.1%)
$945.00 K(-76.6%)
June 2018
-
-$55.00 K(-104.5%)
$4.04 M(-42.3%)
Mar 2018
-
$1.23 M(-4210.0%)
$6.99 M(+22.2%)
Dec 2017
$5.72 M(-77.5%)
-$30.00 K(-101.0%)
$5.72 M(+2.3%)
Sept 2017
-
$2.89 M(-0.3%)
$5.59 M(-80.3%)
June 2017
-
$2.90 M(-7728.9%)
$28.44 M(+10.0%)
Mar 2017
-
-$38.00 K(-76.3%)
$25.85 M(+1.7%)
Dec 2016
$25.42 M(+3967.8%)
-$160.00 K(-100.6%)
$25.42 M(-3.8%)
Sept 2016
-
$25.74 M(+8257.8%)
$26.42 M(+3358.5%)
June 2016
-
$308.00 K(-166.1%)
$764.00 K(+109.9%)
Mar 2016
-
-$466.00 K(-155.5%)
$364.00 K(-41.8%)
Dec 2015
$625.00 K
$839.00 K(+910.8%)
$625.00 K(-98.7%)
DateAnnualQuarterlyTTM
Sept 2015
-
$83.00 K(-190.2%)
$49.80 M(-33.4%)
June 2015
-
-$92.00 K(-55.1%)
$74.72 M(-6.1%)
Mar 2015
-
-$205.00 K(-100.4%)
$79.56 M(-30.7%)
Dec 2014
$114.75 M(+6837.4%)
$50.01 M(+100.0%)
$114.75 M(+77.6%)
Sept 2014
-
$25.00 M(+426.1%)
$64.63 M(+63.2%)
June 2014
-
$4.75 M(-86.4%)
$39.59 M(+6.7%)
Mar 2014
-
$34.98 M(<-9900.0%)
$37.09 M(+2142.7%)
Dec 2013
$1.65 M(-95.5%)
-$107.00 K(+214.7%)
$1.65 M(-95.9%)
Sept 2013
-
-$34.00 K(-101.5%)
$40.66 M(+1.2%)
June 2013
-
$2.26 M(-588.5%)
$40.20 M(+7.9%)
Mar 2013
-
-$462.00 K(-101.2%)
$37.27 M(+0.3%)
Dec 2012
$37.16 M(-9163.7%)
$38.90 M(-7896.2%)
$37.16 M(-1813.3%)
Sept 2012
-
-$499.00 K(-25.7%)
-$2.17 M(+14.2%)
June 2012
-
-$672.00 K(+17.7%)
-$1.90 M(+74.1%)
Mar 2012
-
-$571.00 K(+33.7%)
-$1.09 M(+166.1%)
Dec 2011
-$410.00 K(-100.6%)
-$427.00 K(+86.5%)
-$410.00 K(-106.6%)
Sept 2011
-
-$229.00 K(-268.4%)
$6.22 M(-0.5%)
June 2011
-
$136.00 K(+23.6%)
$6.26 M(-89.3%)
Mar 2011
-
$110.00 K(-98.2%)
$58.30 M(-14.5%)
Dec 2010
$68.17 M(+1386.5%)
$6.21 M(-3251.3%)
$68.17 M(+10.6%)
Sept 2010
-
-$197.00 K(-100.4%)
$61.65 M(-7.6%)
June 2010
-
$52.18 M(+422.7%)
$66.75 M(+358.1%)
Mar 2010
-
$9.98 M(-3309.6%)
$14.57 M(+217.7%)
Dec 2009
$4.59 M(-84.6%)
-$311.00 K(-106.3%)
$4.59 M(-6.3%)
Sept 2009
-
$4.90 M(<-9900.0%)
$4.90 M(-4284.6%)
June 2009
-
-$3000.00(0.0%)
-$117.00 K(-108.3%)
Mar 2009
-
-$3000.00(+200.0%)
$1.41 M(-95.3%)
Dec 2008
$29.78 M(>+9900.0%)
-$1000.00(-99.1%)
$29.78 M(-0.0%)
Sept 2008
-
-$110.00 K(-107.2%)
$29.79 M(-0.4%)
June 2008
-
$1.52 M(-94.6%)
$29.89 M(+5.4%)
Mar 2008
-
$28.37 M(<-9900.0%)
$28.37 M(>+9900.0%)
Dec 2007
$80.00 K(-99.5%)
-
-
June 2007
-
-$2000.00(-103.3%)
$58.00 K(-3.3%)
Mar 2007
-
$60.00 K
$60.00 K
Dec 2006
$15.82 M
-
-

FAQ

  • What is Alimera Sciences annual cash flow from financing activities?
  • What is the all time high annual CFF for Alimera Sciences?
  • What is Alimera Sciences annual CFF year-on-year change?
  • What is Alimera Sciences quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Alimera Sciences?
  • What is Alimera Sciences quarterly CFF year-on-year change?
  • What is Alimera Sciences TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Alimera Sciences?
  • What is Alimera Sciences TTM CFF year-on-year change?

What is Alimera Sciences annual cash flow from financing activities?

The current annual CFF of ALIM is $96.50 M

What is the all time high annual CFF for Alimera Sciences?

Alimera Sciences all-time high annual cash flow from financing activities is $114.75 M

What is Alimera Sciences annual CFF year-on-year change?

Over the past year, ALIM annual cash flow from financing activities has changed by +$96.80 M (+32053.31%)

What is Alimera Sciences quarterly cash flow from financing activities?

The current quarterly CFF of ALIM is -$4.32 M

What is the all time high quarterly CFF for Alimera Sciences?

Alimera Sciences all-time high quarterly cash flow from financing activities is $87.13 M

What is Alimera Sciences quarterly CFF year-on-year change?

Over the past year, ALIM quarterly cash flow from financing activities has changed by -$3.77 M (-690.29%)

What is Alimera Sciences TTM cash flow from financing activities?

The current TTM CFF of ALIM is -$1.97 M

What is the all time high TTM CFF for Alimera Sciences?

Alimera Sciences all-time high TTM cash flow from financing activities is $114.75 M

What is Alimera Sciences TTM CFF year-on-year change?

Over the past year, ALIM TTM cash flow from financing activities has changed by -$98.36 M (-102.05%)